CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...
Toku’s AI (CLAiR) technology platform has received FDA Breakthrough Device status, and if cleared by the FDA will deliver real-time cardiovascular disease (CVD) risk assessments through routine eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback